Back to Search
LARRY SCHLABACH, MD
MD
Medical Oncology Physician
NPI: 1386609394IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD00019043(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE
Class of 1987
Research & Publications (4)
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
PMID 19404213·J Thorac Oncol·2009
3-trial
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.
PMID 15277257·Ann Oncol·2004
3-trial
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
PMID 11205920·Clin Cancer Res·2001
3-trial
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
PMID 10863062·Int J Radiat Oncol Biol Phys·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1208 Pointe Centre Dr Ste 110
Chattanooga, TN 37421 - Phone
- (423) 266-4764
Quick Facts
- NPI
- 1386609394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 39
- Publications
- 4
Are you this provider?
Claim Your Profile